PERTUZUMAB vs PEXIDARTINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
PERTUZUMAB vs PEXIDARTINIB: Safety Overview
| Metric | PERTUZUMAB | PEXIDARTINIB |
|---|---|---|
| Total FAERS Reports | 21,995 | 970 |
| Deaths Reported | 2,161 | 17 |
| Death Rate | 9.8% | 1.8% |
| Hospitalizations | 7,803 | 91 |
| Average Patient Age | 55.8 yrs | 44.9 yrs |
| % Female Patients | 95.9% | 63.4% |
| FDA Approval Date | N/A | Aug 2, 2019 |
| Manufacturer | Genentech, Inc. | Daiichi Sankyo Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | Prescription | Discontinued |